Repligen Corporation

US$173.49As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RGENHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 19.72%
Div yield —
ROE (0.57%)
Medical Instruments & Supplies
Beta (5Y) 1.12
PE TTM —
TSR TTM 16.39%
Mkt cap US$11.09B
ROIC (4.81%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$224
29.33%
(60.92%)
Hold 4|12|1|9|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.99
2.12
2.16
2.13
1.50%
9.25%
7.99%
6.13%
Revenue$M
558.7
549.0
555.5
543.6
16.36%
12.48%
7.77%
1.36%
Peers (US$11.09B)
Cap (US$)
PE
11.70B
24.17x
10.48B
31.05x
Capital
TTM
5Y
10Y
Leveragex
1.107
0.184
0.144
EBIT/Intx
1.031
0.080
0.084
Own earn%
(26.68)
60.77
54.78
Sh yield%
34.51
18.98
18.47
Owners
Insiders/Inst%
13.85
86.07
Short interest%
3.61
SBC / revenue%
2.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
25–32
$1 testx
—
Incr. ROIC%
5